| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.0008 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |